{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:07:32Z","timestamp":1757700452151},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNCI J Natl Cancer Inst"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/jnci\/djw250","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T19:07:07Z","timestamp":1476299227000},"page":"djw250","source":"Crossref","is-referenced-by-count":3,"title":["General Biomarker Recommendations for Lymphoma"],"prefix":"10.1093","volume":"108","author":[{"given":"Lisa","family":"Rimsza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Crump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Baizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W. C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad S.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale","family":"Kostakoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"2016121617452563000_108.12.djw250.1","unstructured":"Swerdlow SH International Agency for Research on Cancer, World Health Organization . WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008."},{"issue":"2","key":"2016121617452563000_108.12.djw250.2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bjh.12880","article-title":"Lymphoma diagnosis at an academic centre: Rate of revision and impact on patient care","volume":"166","author":"Bowen","year":"2014","journal-title":"Brit J Haematol"},{"key":"2016121617452563000_108.12.djw250.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.2223"},{"key":"2016121617452563000_108.12.djw250.4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28676"},{"issue":"3","key":"2016121617452563000_108.12.djw250.5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.semnuclmed.2014.12.001","article-title":"Current image acquisition options in PET\/MR","volume":"45","author":"Boellaard","year":"2015","journal-title":"Sem Nuc Med."},{"issue":"10","key":"2016121617452563000_108.12.djw250.6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00259-013-2465-0","article-title":"Evaluation of strategies towards harmonization of FDG PET\/CT studies in multicentre trials: Comparison of scanner validation phantoms and data analysis procedures","volume":"40","author":"Makris","year":"2013","journal-title":"Eur J Nuc Med and Mol Imaging"},{"issue":"1","key":"2016121617452563000_108.12.djw250.7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nuc Med and Mol Imaging"},{"key":"2016121617452563000_108.12.djw250.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.148056"},{"key":"2016121617452563000_108.12.djw250.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2016121617452563000_108.12.djw250.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"2016121617452563000_108.12.djw250.11","doi-asserted-by":"crossref","unstructured":"Nowakowski GS Blum KA Kahl BS , . Beyond RCHOP: A blueprint for diffuse large B-cell lymphoma research. J Natl Cancer Inst. 2016;djw257 (doi:10.1093\/jnci\/djw257).","DOI":"10.1093\/jnci\/djw257"},{"key":"2016121617452563000_108.12.djw250.12","doi-asserted-by":"crossref","unstructured":"Spurgeon SE Till BG Martin P , . Recommendations for clinical trial development in mantle cell lymphoma. J Natl Cancer Inst. 2016;djw263 (doi:10.1093\/jnci\/djw263).","DOI":"10.1093\/jnci\/djw263"},{"key":"2016121617452563000_108.12.djw250.13","doi-asserted-by":"crossref","unstructured":"Casulo C O\u2019Connor O Shustov A , . T-cell lymphoma: Recent advances in characterization and new opportunities for treatment. J Natl Cancer Inst. 2016;djw248 (doi:10.1093\/jnci\/djw248).","DOI":"10.1093\/jnci\/djw248"},{"key":"2016121617452563000_108.12.djw250.14","doi-asserted-by":"crossref","unstructured":"Diefenbach CS Connors JM Friedberg JW , . Hodgkin lymphoma: Current status and clinical trial recommendations. J Natl Cancer Inst. 2016;djw249 (doi:10.1093\/jnci\/djw249).","DOI":"10.1093\/jnci\/djw249"},{"key":"2016121617452563000_108.12.djw250.15","doi-asserted-by":"crossref","unstructured":"Maddocks M Barr PM Cheson BD , . Recommendations for clinical trial development in follicular lymphoma. J Natl Cancer Inst. 2016;djw255 (doi:10.1093\/jnci\/djw255).","DOI":"10.1093\/jnci\/djw255"}],"container-title":["Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/108\/12\/djw250\/8499140\/djw250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T02:56:35Z","timestamp":1503629795000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djw250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,16]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1093\/jnci\/djw250"],"URL":"https:\/\/doi.org\/10.1093\/jnci\/djw250","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}